4 years ago

An HIF-1α/VEGF-A Axis in Cytotoxic T Cells Regulates Tumor Progression

An HIF-1α/VEGF-A Axis in Cytotoxic T Cells Regulates Tumor Progression
Jonas Bergh, Theodoros Foukakis, Thomas Hatschek, Ingrid Hedenfalk, Anthony T. Phan, Helene Rundqvist, Niklas Loman, Randall S. Johnson, Asis Palazon, Susan Fitzpatrick, David Macias, Ananda W. Goldrath, Petros A. Tyrakis, John Lövrot, Nikola Vojnovic, Pedro Veliça

Summary

Cytotoxic T cells infiltrating tumors are thought to utilize HIF transcription factors during adaptation to the hypoxic tumor microenvironment. Deletion analyses of the two key HIF isoforms found that HIF-1α, but not HIF-2α, was essential for the effector state in CD8+ T cells. Furthermore, loss of HIF-1α in CD8+ T cells reduced tumor infiltration and tumor cell killing, and altered tumor vascularization. Deletion of VEGF-A, an HIF target gene, in CD8+ T cells accelerated tumorigenesis while also altering vascularization. Analyses of human breast cancer showed inverse correlations between VEGF-A expression and CD8+ T cell infiltration, and a link between T cell infiltration and vascularization. These data demonstrate that the HIF-1α/VEGF-A axis is an essential aspect of tumor immunity.

Publisher URL: http://www.cell.com/cancer-cell/fulltext/S1535-6108(17)30456-7

DOI: 10.1016/j.ccell.2017.10.003

You might also like
Discover & Discuss Important Research

Keeping up-to-date with research can feel impossible, with papers being published faster than you'll ever be able to read them. That's where Researcher comes in: we're simplifying discovery and making important discussions happen. With over 19,000 sources, including peer-reviewed journals, preprints, blogs, universities, podcasts and Live events across 10 research areas, you'll never miss what's important to you. It's like social media, but better. Oh, and we should mention - it's free.

  • Download from Google Play
  • Download from App Store
  • Download from AppInChina

Researcher displays publicly available abstracts and doesn’t host any full article content. If the content is open access, we will direct clicks from the abstracts to the publisher website and display the PDF copy on our platform. Clicks to view the full text will be directed to the publisher website, where only users with subscriptions or access through their institution are able to view the full article.